Suzanne Scheele

发表

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

C. Dye, V. Pathania, M. Raviglione, 1999, JAMA.

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China.

C. Dye, Brett Williams, S. Scheele, 2000, International journal of epidemiology.

Global burden of tuberculosis

Christopher Dye, Vikram Pathania, C. Dye, 1999 .

SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1

Dustin J Maly, W. Hol, M. Parsons, 2015, ACS medicinal chemistry letters.

Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.

Dustin J Maly, K. Comess, C. Verlinde, 2014, ACS medicinal chemistry letters.

Measuring tuberculosis burden, trends, and the impact of control programmes.

B G Williams, H L Rieder, C. Dye, 2008, The Lancet. Infectious diseases.

What Drives the Value of a Shigella Vaccine?

B. Giersing, William P. Hausdorff, S. Scheele, 2022, Vaccines.

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study

K. Bagamian, William P. Hausdorff, John D. Anderson, 2023, The Lancet. Global health.

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study

K. Bagamian, William P. Hausdorff, John D. Anderson, 2023, The Lancet. Global health.

Health statistics: time to get serious.

K. Shibuya, T. Boerma, S. Scheele, 2005, Bulletin of the World Health Organization.

Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.

Dustin J Maly, M. Parsons, A. DeRocher, 2018, The Journal of infectious diseases.

Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.

Dustin J Maly, M. Parsons, S. Dangoudoubiyam, 2016, International journal for parasitology.

Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.

Dustin J Maly, W. Hol, M. Parsons, 2016, Journal of medicinal chemistry.